University of Wisconsin-Madison researchers are studying whether a drug used for organ transplant patients could slow aging in humans.
Some compelling evidence in recent decades shows rapamycin — also known as sirolimus — can increase the quality and quantity of life in animals, said Adam Konopka, a UW-Madison assistant professor of geriatrics and gerontology.
“This got people really excited that maybe this drug could be used to improve human healthy longevity,” he said.